Ellevest Inc’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-196
Closed -$18K 1731
2021
Q4
$18K Buy
196
+79
+68% +$5.21K ﹤0.01% 738
2021
Q3
$7K Sell
117
-81
-41% -$4.79K ﹤0.01% 909
2021
Q2
$14K Buy
198
+120
+154% +$7.82K ﹤0.01% 711
2021
Q1
$5K Buy
78
+55
+239% +$4.23K ﹤0.01% 924
2020
Q4
$2K Buy
23
+8
+53% +$600 ﹤0.01% 1011
2020
Q3
$1K Buy
+15
New +$1K ﹤0.01% 1095
2020
Q2
Sell
-3
Closed 1420
2020
Q1
$0 Sell
3
-11
-79% -$504 ﹤0.01% 1370
2019
Q4
$1K Buy
+14
New +$662 ﹤0.01% 925

Ellevest Inc's ARNA Position: Q1 2022 in Review

Ellevest Inc sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 196 shares — an estimated $18K sold.

Ellevest Inc first reported a position in ARNA in Q4 2019 and held it in 8 quarters. The position peaked at $18K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Ellevest Inc reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Ellevest Inc sold 196 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $18K.
  • Ellevest Inc first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 8 quarters.
  • Ellevest Inc's Arena Pharmaceuticals Inc position peaked at $18K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Ellevest Inc's 13F filing for Q1 2022, filed 19 Apr 2022.